Risk Of Obstructive Sleep Apnea Syndrome In An Adult Population With Hiv Infection In Southwest Nigeria

Article Sidebar

PDF EPUB
Published: 2020-11-30
DOI: https://doi.org/10.82222/njcd.vol2no1.52
Keywords:
STOP-BANG, PLWH, OSAS

Main Article Content

A. O. Odeyemi
Department of Medicine, College of Health Sciences, Bowen University, Ogbomoso, Oyo State, Nigeria.
A. O. Ala
Department of Medicine, College of Health Sciences, Bowen University, Ogbomoso, Oyo State, Nigeria.
O. O. Ogunwobi
Department of Medicine, College of Health Sciences, Bowen University, Ogbomoso, Oyo State, Nigeria.
A. O. Odeyemi
Department of Paediatrics, College of Health Sciences, Bowen University, Ogbomoso, Oyo State, Nigeria.
O. O. Oni
Department of Medicine, College of Health Sciences, Bowen University, Ogbomoso, Oyo State, Nigeria.
G. M. Israel
Department of Medicine, College of Health Sciences, Bowen University, Ogbomoso, Oyo State, Nigeria.
D. O. Oyewusi
Department of Medicine, College of Health Sciences, Bowen University, Ogbomoso, Oyo State, Nigeria.

Abstract

Background: Emerging data suggest that obstructive sleep apnea syndrome (OSAS) is common among people living with HIV (PLWH). The burden of HIV infection in Nigeria is high. Unrecognized and untreated OSAS have a significant impact on the quality of life and may affect the gains of successful treatment of HIV. The study was carried out to determine the proportion of an adult population of PLWH in South-western Nigeria who have a high risk for OSAS and the associated risk factors.


Study design: A cross-sectional survey of 198 adults attending the clinic dedicated to PLWH at Bowen University Teaching Hospital (BUTH), Ogbomoso was done using the STOP-BANG questionnaire. Data collected include socio-demographic characteristics and anthropometric measurements. The blood pressure and BMI were measured and calculated respectively. Factors associated with high risk for OSAS were identified. 


Results: Of the 198 participants, 73.2% were females. Forty (20.2%) had a high risk for OSAS and the factors associated with this risk include male sex, age, BMI, neck circumference, hypertension and use of antiretroviral therapy (ART) regimen containing zidovudine (AZT) and protease inhibitors (PI). Duration on ART and CD4 count did not show a relationship with the risk of OSAS.


Conclusion: The risk of OSAS is high in a significant proportion of an adult population of PLWH in South-western Nigeria and this risk is related to age, male sex, BMI, neck circumference, hypertension and use of ART regimen containing AZT and PI.

Downloads

Download data is not yet available.

Article Details

Issue

Vol. 2 No. 1 (2020): November

Section

Original Articles
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This is an open-access article distributed under the terms   This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

How to Cite

Odeyemi, A. O., Ala, A. O., Ogunwobi, O. O., Odeyemi, A. O., Oni, O. O., Israel, G. M., & Oyewusi, D. O. (2020). Risk Of Obstructive Sleep Apnea Syndrome In An Adult Population With Hiv Infection In Southwest Nigeria. Nigerian Journal of Chest Diseases, 2(1), 79-85. https://doi.org/10.82222/njcd.vol2no1.52

References

1. McNicholas WT, Bonsignore MR, Management Committee of EU COST ACTION B26. Sleep apnoea as an independent risk factor for

cardiovascular disease: current evidence, basic mechanisms and research priorities. Eur Respir J 2007; 29: 156-78.

2. Babu AR, Herdegen J, Fogelfeld L, Shott S, Mazzone T. Type 2 diabetes, glycemic control, and continuous positive airway pressure in obstructive sleep apnea. Arch Intern Med 2005; 165: 447–452.

3. Yaffe K, Laffan AM, Harrison SL, Redline S, Spira AP, Ensrud KE et al. Sleep-disordered breathing, hypoxia, and risk of mild cognitive impairment and dementia in older women. JAMA 2011; 306: 613–619.

4. Young T, Peppard P, Palta M, Hla KM, Finn L, Morgan B, et al. Population-based study of sleep-disordered breathing as a risk factor for hypertension. Arch Intern Med 1997; 157: 1746–1752.

5. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000; 342: 1378–1384.

6. Nieto FJ, Young TB, Lind BK, Shahar E, Samet JM, Redline S, et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA 2000; 283: 1829–1836.

7. Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005; 365: 1046–1053.

8. Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 2005; 353: 2034–2041.

9. Mehra R, Stone KL, Varosy PD, Hoffman AR, Marcus GM, Blackwell T, et al. Nocturnal Arrhythmias across a spectrum of obstructive and central sleep-disordered breathing in older men: outcomes of sleep disorders in older men (MrOS sleep) study. Arch Intern Med 2009;

169: 1147–1155.

10. Peppard PE, Young T, Barnet JH, Palta M, Hagen EW, Hla KM. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol. 2013;177(9):1006-1014.

11. Olanisun Olufemi Adewole, Adeyemo Hakeem, Ayeni Fola, Emmanuel Anteyi, Zaccheus Ajuwon and Greg Erhabor. Obstructive Sleep Apnea Among Adults in Nigeria. J NATL MED ASSOC 2009; 101(7): 720-725.

12. Young T, Skatrud J, Peppard PE. Risk factors for obstructive sleep apnea in adults. JAMA. 2004 Apr 28; 291(16):2013-6.

13. H. KlarYaggi and Kingman P.Strohl. Adult Obstructive Sleep Apnea/Hypopnea Syndrome: Definitions, Risk Factors, and Pathogenesis. Clin Chest Med 2010; 31: 179–186.

14. Howard ME, Desai AV, Grunstein RR, Hukins C, Armstrong JG, Joffe D et al. Sleepiness, sleepdisordered breathing, and accident risk factors in commercial vehicle drivers. Am J Respir Crit Care Med 2004; 170: 1014–1021.

15. Teran-Santos J, Jimenez-Gomez A, Cordero-Guevara J. The association between sleep apnea and the risk of traffic accidents. Cooperative Group BurgosSantander. N Engl J Med 1999; 340: 847–851.

16. Deeks SG, Lewin SR, Havlir DV. The end of AIDS: HIV infection as a chronic disease. Lancet 2013; 382:1525–33.

17. Johnson AS, Hall HI, Hu X, Lansky A, Holtgrave DR, Mermin J. Trends in diagnoses of HIV infection in the United States, 2002–2011. JAMA 2014; 312:432–4.

18. Lakey W, Yang LY, Yancy W, Chow SC, Hicks C. Short communication: from wasting to obesity: initial antiretroviral therapy and weight gain in HIV-infected persons. AIDS Res Hum Retroviruses 2013; 29:435–40.

19. Pullinger CR, Aouizerat BE, Gay C, Coggins T, Movsesyan I, Davis H, et al. Metabolic abnormalities and coronary heart disease risk in human

immunodeficiency virus-infected adults. Metab Syndr Relat Disord 2010; 8:279–86.

20. Taibi DM. Sleep disturbances in persons living with HIV. J Assoc Nurses AIDS Care 2013; 24(1 Suppl): S72–85.

21. Lo Re 3rd V, Schutte-Rodin S, Kostman JR. Obstructive sleep apnoea among HIV patients. Int J STD AIDS. 2006;17(9):614–20.

22. Dorey-Stein Z, Amorosa VK, Kostman JR, Lo Re 3rd V, Shannon RP. Severe weight gain, lipodystrophy, dyslipidemia, and obstructive sleep apnea in a human immunodeficiency virus-infected patient following highly active antiretroviral therapy. J Cardiometab Syndr. 2008;3(2):111–4.

23. Epstein LJ, Strollo Jr PJ, Donegan RB, Delmar J, Hendrix C, Westbrook PR. Obstructive sleep apnea in patients with human immunodeficiency virus (HIV) disease. Sleep. 1995;18(5):368–76.

24. Todd T. Brown, Susheel P. Patil, Lisa P. Jacobson, Joseph B. Margolick, Alison M. Laffan, Rebecca J Godfrey et al. Anthropometry in the Prediction of Sleep Disordered Breathing in HIV-infected and - uninfected Men. Antivir Ther. 2010; 15(4): 651–659.

25. Lo JC, Mulligan K, Tai VW, Algren H, Schambelan M. “Buffalo hump” in men with HIV-1 infection. Lancet. 1998; 351(9106): 867–70.

26. National Agency for the Control of AIDS (NACA), Federal Republic of Nigeria. National Strategic Framework on HIV and AIDS: 2017-2021. Abuja, Nigeria. NACA, 2018.

27. National Institutes of Health. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. Obes Res 1998 Nov; 6(6):464.

28. Camille Vatier, Christine Poitou and Karine Clement. Evaluation of Visceral Fat in Massive Obesity. In: Ronald Ross Watson, (ed.) Nutrition in the Prevention and treatment of Abdominal Obesity. London, Elsevier Inc. 2014. P. 67-77.

29. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003 Dec. 42(6):1206-52.

30. Chung F, Abdullah HR, Liao P. STOP-bang questionnaire: A Practical approach to screen for obstructive sleep apnea. Chest 2016;149:631-8

31. Chung F, Yegneswaran B, Liao P, Vairavanathan S, Islam S, Khajehdehi A, et al. STOP questionnaire: a tool to screen patients for obstructive sleep apnea. Anesthesiology. 2008; 108(5): 812-821.

32. Andreas Ateke Njoh, Eta Ngole Mbong, Valeri Oben Mbi, Michel Karngong Mengnjo, Leonard Njamnshi Nfor, Leonard Ngarka et al. Likelihood of obstructive sleep apnea in people living with HIV in Cameroon – preliminary findings. Sleep Science and Practice 2017; 1:4.

33. KM Kunisaki, KM Akgün, DA Fiellin, CL Gibert, JW Kim, D Rimland et al. Prevalence and correlates of obstructive sleep apnoea among patients with and without HIV infection. HIV Medicine 2015; 16: 105–113.

34. Robert L. Owens and Charles B. Hicks. A Wake-up Call for Human Immunodeficiency Virus (HIV) Providers: Obstructive Sleep Apnea in People Living With HIV. CID 2018; 67(3): 472–6.

35. Kapur VK. Obstructive sleep apnea: diagnosis, epidemiology, and economics. Respir Care 2010;55:1155-67.

36. Malhotra A, Huang Y, Fogel R, Lazic S, Pillar G, Jakab M, et al. Aging influences on pharyngeal anatomy and physiology: the predisposition to pharyngeal collapse. Am J Med 2006; 119: 72.e9-14.

37. Hedner J, Bengtsson-Bostrom K, Peker Y, Grote L, Råstam L and Lindblad U. Hypertension prevalence in obstructive sleep apnoea and sex: a population-based casecontrol study. Eur Respir J 2006; 27: 564-70.

38. Gozal D, Kheirandish-Gozal L. Cardiovascular morbidity in obstructive sleep apnea: oxidative stress, inflammation, and much more. Am J Respir Crit Care Med. 2008 Feb 15. 177(4):369-75.

39. Peppard PE, Young T, Palta M, Dempsey J and Skatrud J. Longitudinal study of moderate weight change and sleepdisordered breathing. JAMA 2000;284:3015-21.

40. Punjabi NM. The epidemiology of adult obstructive sleep apnea. Proc Am Thorac Soc 2008;5:136-43.

41. Schwartz AR, Patil SP, Squier S, Kirkness JP and Smith PL. Obesity and upper airway control during sleep. J Appl Physiol (1985) 2010; 108: 430-5.

42. Shelton KE, Woodson H, Gay S and Suratt PM. Pharyngeal fat in obstructive sleep apnea. Am Rev Respir Dis 1993; 148: 462-6.

43. Steier J, Lunt A, Hart N, Polkey MI and Moxham J. Observational study of the effect of obesity on lung volumes. Thorax 2014; 69: 752-9.

44. Onat A, Hergenc G, Yüksel H, Can G, Ayhan E, Kaya Z, et al. Neck circumference as a measure of central obesity: associations with metabolic syndrome and obstructive sleep apnoea syndrome beyond waist circumference. Clin Nutr. 2009;28:46–51.

45. Soylu AC, Levent E, Sariman N, Yurtlu S, Alparslan S, Saygı A. Obstructive sleep apnea syndrome and anthropometric obesity indexes. Sleep Breath. 2012;16(4):1151–58.

46. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993 Apr 29; 328(17): 1230-5.

47. Redline S, Kump K, Tishler PV, Browner I, Ferrette V. Gender differences in sleep disordered breathing in a community-based sample. Am J Respir Crit Care Med. 1994 Mar; 149(3 Pt 1): 722-6.

48. Carr A. HIV lipodystrophy: risk factors, pathogenesis, diagnosis and management. AIDS 2003;17 (Suppl 1):S141–8.

49. Martinez E, Mocroft A, Garcia-Viejo MA, Pérez-Cuevas JB, Blanco JL, Mallolas J, et al. Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort study. Lancet 2001; 357(9256):592–8.

50. Kim DJ, Westfall AO, Chamot E, Willig AL, Mugavero MJ, Ritchie C, et al. Multimorbidity patterns in HIVinfected patients: the role of obesity in chronic disease clustering. J Acquir Immune Defic Syndr 2012; 61: 600–605.

51. Amorosa V, Synnestvedt M, Gross R, Friedman H, MacGregor R R, Gudonis D, et al. A tale of 2 epidemics: the intersection between obesity and HIV infection in Philadelphia. J Acquir Immune Defic Syndr 2005;39(5):557–61